5,045
edits
27. Drugs that increase regional blood flow. Drug treatment of obesity: Difference between revisions
27. Drugs that increase regional blood flow. Drug treatment of obesity (view source)
Revision as of 13:01, 7 June 2023
, 7 June 2023→Introduction to obesity
(Created page with "== Introduction to drugs used to enhance regional blood flow == These drugs are used to enhance perfusion of organs, either because they require more perfusion or because their perfusion has been compromised by vasospasm or atherosclerosis. More precisely, these drugs are useful in peripheral artery disease-induced intermittent claudication, erectile dysfunction and Raynaud phenomenon. In cases where one artery is blocked by atherosclerotic regions, giving drugs to enha...") |
|||
| Line 131: | Line 131: | ||
=== Lorcaserin === | === Lorcaserin === | ||
Lorcaserin is not available for use in the EU and for that reason is probably not that important. It's a 5-HT2C receptor agonist, which suppresses the appetite. | Lorcaserin is not available for use in the EU and for that reason is probably not that important. It was approved in the US but the approval was withdrawn in 2020 due to studies showing it causing an increased risk of cancer. It's a 5-HT2C receptor agonist, which suppresses the appetite. | ||
=== Phentermine, benzphetamine === | === Phentermine, benzphetamine === | ||